[Effect of L-dopa on pituitary hormones and on carbohydrate and fat metabolism in normal persons and in patients with Parkinsonism].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000941:Antigens; D001786:Blood Glucose / Q000378:metabolism*; D002262:Carboxy-Lyases / Q000008:administration & dosage; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage*; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005640:Follicle Stimulating Hormone / Q000097:blood; D005990:Glycerol / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007267:Injections; D007328:Insulin / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000097:blood*; D010908:Pituitary Hormones, Anterior / Q000097:blood*
D000941:Antigens; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D010908:Pituitary Hormones, Anterior; D004295:Dihydroxyphenylalanine; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone; D002262:Carboxy-Lyases; D005990:Glycerol; D006854:Hydrocortisone
Untersuchungen über die Wirkung von L-Dopa auf Hormone des Hypophysenvorderlappens und auf den Kohlenhydrat- und Fettsoffwechsel bei Normalpersonen und bei Morbus Parkinson.